Hodgkin Lymphoma — Trials

Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

972 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 179
Recruiting: 90
Ph III recruiting: 6
Growth YoY: −4.2%
Industry share: 11%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%
Trials / 1,000 deaths: 175.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07838649	Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity	not yet recruiting	Phase 1	36	Washington University School of MedicineOTHER	1	Sep 24, 2026	clinicaltrials
NCT07729397	Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)(ANCILE-30)	not yet recruiting	Phase 1	21	The Methodist Hospital Research InstituteOTHER	1	Jul 27, 2026